A series of biochemical and genetic assays elucidates a mechanism by which BRAFV600E mutant cancers circumvent the efficacy of 5-FU induced DNA damage through a previously undescribed GLI1-mediated transcription of the DNA damage-sensing protein NBS1. Here, GLI1 is linked to cancer.